In conclusion, our transcriptome profiling of primary tumors from our somatic model of breast cancer suggests Nr5a2 is a key mediator involved in mutant p53-driven transcriptional rewiring in breast cancers. This evidence concerns the gene NR5A2 and breast carcinoma.